UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): March 17, 2009
IntegraMed America, Inc.
(Exact Name of Registrant as Specified in Charter)
Delaware |
|
0-20260 |
|
6-1150326 |
(State or Other Jurisdiction of Incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer Identification No.) |
Two Manhattanville Road, Purchase, NY 10577
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (914) 253-8000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. Other Events.
|
On March 17, 2009, IntegraMed America, Inc. issued a press release, which is attached hereto as Exhibit 99.1. |
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
|
99.1 |
Press Release of IntegraMed America, Inc. dated March 17, 2009 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
INTEGRAMED AMERICA, INC. |
|
|
|
(Registrant) |
|
|
Date: March 17, 2009 |
|
|
|
|
By: |
/s/ John W. Hlywak, Jr. |
|
|
|
Name: John W. Hlywak, Jr. |
|
|
|
Title: Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)
|
|